Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Warrington, Pennsylvania 18976


Lung wash with KL₄Surfactant of individual lung segments using a bronchoscope compared to usual care alone consisting primarily of assisted (mechanical) ventilation in patients with acute respiratory distress syndrome(ARDS).

Study summary:

This is a multinational, multicenter, two-part, Phase 2 study that will evaluate the tolerability, safety, and efficacy of KL₄Surfactant in adult ARDS patients when administered by sequential bronchoscopic lavage into each of the 19 bronchopulmonary segments of the lung and as a bolus instillation into each lung.


Inclusion Criteria: - Intubated and required mechanical ventilation support - Met the criteria for ARDS - Partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) ≤ 200 mmHg and ≥ 60 mmHg within 60 minutes before randomization - Mean blood pressure was ≥ 60 mmHg immediately before randomization Exclusion Criteria: - Had ARDS due solely to a major trauma - Was currently participating in another clinical trial or received an experimental drug or device within the previous month - A woman of childbearing age, unless pregnancy was excluded by a negative urine hCG test or if the subject was surgically incapable of childbearing - Had a previous episode of ARDS that resolved and then recurred during the current hospitalization - Had a disease that was sufficiently advanced, in the best judgment of the Principal Investigator, to markedly limit life expectancy to < 6 months - Was known to have AIDS or symptomatic HIV (CD4 counts <500). Subjects with asymptomatic HIV were not excluded - Received chemotherapy or radiation within the previous 90 days - Received an organ transplant other than corneal transplants - Received, or was currently receiving, immunosuppression therapy within the last 6 months - Had severe neurological damage or the presence of a disease that was likely to significantly prevent weaning from the ventilator - Had a best Glasgow Coma Score (GCS) of ≤ 8 or an intracranial pressure ≥ 20 cm H2O prior to the institution of sedatives or paralysis



Primary Contact:

Study Director
Timothy J Gregory, PhD
Windtree Therapeutics

Backup Contact:


Location Contact:

Warrington, Pennsylvania 18976
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.